Unfractionated heparin dosing nomograms: Road maps to where?

Pharmacotherapy

Volumn 24, Issue 8 II, 2004, Pages

  Dobesh, Paul P ^a,b  

^a ST LUKE S HOSPITAL   (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

Author keywords

Activated partial thromboplastin time; Nomograms; Standard dosing; Thrombosis; Unfractionated heparin; Weight based dosing

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; THROMBOEMBOLISM; TREATMENT OUTCOME;

BODY WEIGHT; CLINICAL PROTOCOLS; CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PARTIAL THROMBOPLASTIN TIME;

EID: 3543081470     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.12.142S.36113     Document Type: Conference Paper

References (11)

1. Saya FG, Coleman LT, Martinoff JT. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm 1985;42:1965-9.
2. Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589-95.
3. Rivey MP, Peterson JF. Pharmacy-managed, weight-based heparin protocol. Am J Hosp Pharm 1993;50:279-84.
4. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with 'standard care' nomogram. Ann Intern Med 1993;119:874-81.
5. Gunnarsson PD, Sawyer WT, Montague D, Williams ML, Dupuis RE, Caiola SM. Appropriate use of heparin: empiric vs. nomogram-based dosing. Arch Intern Med 1995;155:526-32.
6. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of acute myocardial infarction). J Am Coll Cardiol 1999;34:890-911.
7. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with unstable angina). Available from http://www.acc.org/clinical/ guidelines/unstable/unstable.pdf. Accessed April 15, 2004.
8. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy Arch Intern Med 1991;151:333-7.
9. Ansara AJ, Dobesh PP, Abu-Shanab JR, Enders JM. Preventing sub-therapeutic anticoagulation with a weight-based heparin nomogram in the treatment of venous thromboembolism [abstr]. Pharmacotherapy 2003;23:1341.
10. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001:119:64S-94.
11. Hylek EM, Regan S, Henault LE, et al. Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis. Arch Intern Med 2003;163:621-7.